Export of Pharma Grade Sugar Capped at 25,000 MT Per Year Under DGFT’s New Policy

The Directorate General of Foreign Trade (DGFT) has implemented a new policy that restricts the export of pharma-grade sugar, capping the total annual export quantity at 25,000 metric tonnes. This move places the specialized sugar, which is a critical raw material for various pharmaceutical formulations like syrups and tablets, under the "Restricted" export category. The decision to cap the exports is aimed at ensuring sufficient domestic availability of this crucial ingredient for India's pharmaceutical industry. By limiting the amount that can be sold overseas, the government seeks to maintain stable domestic prices and prevent any potential shortages that could disrupt the production of essential medicines. This policy reflects a strategic approach to balance the interests of sugar exporters with the need to safeguard the country's pharmaceutical supply chain and ensure national health security.